Advertisement

Narkose zur Elektrokrampftherapie

  • U. Grundmann
  • S.O. Schneider

Zusammenfassung

Die Elektrokrampftherapie zählt zu den etablierten Behandlungsmaßnahmen bei einem breiten Spektrum schwerer psychiatrischer Erkrankungen. Das Verfahren, bei dem ein generalisierter epileptischer Krampfanfall durch elektrische Stimulation des Gehirns ausgelost wird, erfolgt unter Narkose und Muskelrelaxation. Ausreichende Kenntnisse der physiologischen und pharmakologischen Besonderheiten sind dabei notwendige Voraussetzungen für die sichere Narkoseführung, In der vorliegenden Übersicht werden aktuelle Aspekte zum Verfahren und anästhesiologisehen Vorgehen vorgestellt.

Schlüsselwörter

Krampfanfall Psychiatrische Erkrankungen Anästhetika, intravenös Hypnotika Muskelrelaxanzien 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. 1.
    Gaynes BN, Warden D, TrivediMH et al (2009) What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 60:1439–1445PubMedGoogle Scholar
  2. 2.
    Loh N, Nickl-JockschatT, Sheldrick AJ, Grözinger M (2012) Accessibility, Standards and challenges of electroconvulsive therapy in Western industriali-zed countries: a German example. World J Biol Psychiatry. DOI 10.3109/15622975.2012.665176Google Scholar
  3. 3.
    Müller U, Klimke A, Jänner M, GaebelW (1998) Die Elektrokrampftherapie in psychiatrischen Kliniken der Bundesrepublik Deutschland 1995. Nervenarzt 69:15–26PubMedGoogle Scholar
  4. 4.
    Leiknes KA, Jarosh-von Schweder L, H0ie B (2012) Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav 2:283–344Google Scholar
  5. 5.
    Payne NA, Prudic J (2009) Electroconvulsive therapy: part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract 15:346–368PubMedPubMedCentralGoogle Scholar
  6. 6.
    Perrin JS, Merz S, Bennett DM et al (2012) Electroconvulsive therapy reduces frontal cortical Connectivity in severe depressive disorder. Proc Natl Acad Sei U S A 109:5464546–8Google Scholar
  7. 7.
    Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Bündesärztekammer, Kassenärztliche Bundesvereinigung et al für die Leitliniengruppe Unipolare Depression (Hrsg) (2009) SSLeitlinie/Nationale VersorgungsLeitlinie Unipolare DepressionLangfassung Version 1.3 Januar 2012. http://www.depression.versorgungsleitlinien.de/
  8. 8.
    Deutsche Gesellschaft für Bipolare Störungen und Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (2012) S3-Leitlinie zur Diagnostik und Therapie bipolarer Störungen Langversion 2012. http://www.leitliniebipolar.de
  9. 9.
    Folkerts HW (2011) Elektrokrampftherapie. Indikation, Durchführung und Behandlungsergebnisse. Nervenarzt 82:93–103Google Scholar
  10. 10.
    Folkerts H, Remschmidt H, Saß H et al (2003) Bekanntmachungen: Stellungnahme zur Elektrokrampftherapie (EKT) als psychiatrische Behandlungsmaßnahme. Dtsch Artztebl 100:A504–A506Google Scholar
  11. 11.
    Petrides G, Fink M, Husain MM et al (2001) ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 17:244–253PubMedGoogle Scholar
  12. 12.
    Kellner CH, Fink M, Knapp R et al (2005) Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 162:977–982PubMedPubMedCentralGoogle Scholar
  13. 13.
    BaghaiTC, Möller HJ (2008) Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci 10:105–117Google Scholar
  14. 14.
    Sartorius A (2009) Elektrokrampftherapie. Psychiatr Psychother up2date 3:165–178Google Scholar
  15. 15.
    Shiwach RS, Reid WH, CarmodyTJ (2001) An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. Psychiatr Serv 52:1095–1097PubMedGoogle Scholar
  16. 16.
    Nuttall GA, Bowersox MR, Douglass SB et al (2004) Morbidity and mortality in the use of electroconvulsive therapy. J ECT 20:237–241PubMedGoogle Scholar
  17. 17.
    Watts BV, Groft A, Bagian JP, Mills PD (2011) An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT 27:105–108PubMedGoogle Scholar
  18. 18.
    Devanand DP, DworkAJ, Hutchinson ER et al (1994) Does ECT alter brain strueture? Am J Psychiatry 151:957–970PubMedGoogle Scholar
  19. 19.
    Kayser S, Walter H, SchläpferT (2010) Elektrokrampftherapie und neue Hirnstimulationsmethoden. Nervenheilkunde 29:117–123Google Scholar
  20. 20.
    Deiner S, Frost EA (2009) Electroconvulsive therapy and anesthesia. IntAnesthesiol Clin 47:81–92Google Scholar
  21. 21.
    Saito S (2005) Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth 19:142–149PubMedGoogle Scholar
  22. 22.
    Welch CA, Drop LJ (1989) Cardiovascular effects of ECT. Convuls Ther 5:35–43PubMedGoogle Scholar
  23. 23.
    Deckert D, Zecha-Stallinger A, Haas T et al (2007) Anästhesie außerhalb des Zentral-OP. Anaesthesist 56:1028–1037Google Scholar
  24. 24.
    Tess AV, Smetana GW (2009) Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med 360:1437–1444PubMedGoogle Scholar
  25. 25.
    Grundmann U, Oest M (2007) Anästhesiologische Aspekte bei Elektrokrampftherapie. Anaesthesist 56:202–211Google Scholar
  26. 26.
    Hooten WM, Rasmussen KG Jr (2008) Effects of general anesthetic agents in adults reeeiving electroconvulsive therapy: a systematic review.J ECT 24:208–223PubMedGoogle Scholar
  27. 27.
    Gajwani P, Muzina D, Gao K, Calabrese JR (2006) Awareness under anesthesia during electroconvulsive therapy treatment. J ECT 22:158-159 PubMedCrossRefGoogle Scholar
  28. 1.
    Litt L, Li D (2007) Awareness without recall during anesthesia for electroconvulsive therapy. Anesthesiology 106:871–872PubMedCrossRefGoogle Scholar
  29. 2.
    Hanss R, Bauer M, Bein B et al (2006) Bispectral index-controlled anaesthesia for electroconvulsive therapy. Eur J Anaesthesiol 23:202–207PubMedGoogle Scholar
  30. 3.
    White PF, Rawal S, Recart A et al (2003) Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy? Anesth Anaig 96:1636163–9Google Scholar
  31. 4.
    Cook A, Stevenson G, Scott AI (2000) A survey of methohexitone use by anesthetists in the clinical practice of ECT in Edinburgh. J ECT16:350–355Google Scholar
  32. 5.
    Mokriski BK, Nagle SE, Papuchis GC etal (1992) Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth 4:208–212PubMedGoogle Scholar
  33. 6.
    Swaim JC, Mansour M, Wydo SM, Moore JL (2006) A retrospective comparison of anesthetic agents in electroconvulsive therapy. J ECT 22:243–246PubMedGoogle Scholar
  34. 7.
    Fear CF, Littlejohns CS, Rouse E, McQuail P (1994) Propofol anaesthesia in electroconvulsive therapy. Reduced seizure duration may not be relevant. Br J Psychiatry 165:506–509PubMedGoogle Scholar
  35. 8.
    Geretsegger C, Nickel M, Judendorfer B et al (2007) Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive Performance. J ECT 23:239–243PubMedGoogle Scholar
  36. 9.
    Malsch E, Gratz I, Mani S et al (1994) Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia. ConvulsTher 10:212–219Google Scholar
  37. 10.
    Abdollahi MH, Izadi A, Hajiesmaeili MR et al (2012) Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double-blind controlled clinical trial. J ECT 28:101–3Google Scholar
  38. 11.
    Eranti SV, Mogg AJ, Pluck GC et al (2009) Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. J Affect Disord 113:165–171PubMedGoogle Scholar
  39. 12.
    Tan HL, Lee CY (2009) Comparison between the effects of propofol and etomidate on motor and electroencephalogram seizure duration during electroconvulsive therapy. Anaesth Intensive Care 37:807–814Google Scholar
  40. 13.
    Akcaboy ZN, Akcaboy EY, Yigitbast B et al (2005) Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol Scand 49:1068–1071PubMedGoogle Scholar
  41. 14.
    Chen ST (2011) Remifentanil: a review of its use in electroconvulsive therapy. J ECT 27:323–327PubMedGoogle Scholar
  42. 15.
    Dinwiddie SH, Glick DB, Goldman MB (2012) The effect of propofol-remifentanil anesthesia on selected seizure quality indices in electroconvulsive therapy. Brain Stimul 5:402–407PubMedGoogle Scholar
  43. 16.
    Toprak Hl, Gedik, Begeg Z et al (2005) Sevoflurane as an alternative anaesthetic for electroconvulsive therapy. J ECT 21:108–110PubMedGoogle Scholar
  44. 17.
    Rasmussen KG, Laurila DR, Brady BM et al (2007) Anesthesia outcomes in a randomized double-blind trial of sevoflurane and thiopental for induction of general anesthesia in electroconvulsive therapy. J ECT 23:236–238PubMedGoogle Scholar
  45. 18.
    Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72:537–547Google Scholar
  46. 19.
    Loo CK, Katalinic N, Garfield JB (2012) Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord 142:233–240PubMedGoogle Scholar
  47. 20.
    Okamoto N, Nakai T, Sakamoto K et al (2010) Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatmentresistant depression: comparing ketamine and propofol anesthesia. J ECT 26:223–227PubMedGoogle Scholar
  48. 21.
    Wang X, Chen Y, Zhou X et al (2012) Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT 28:128–132PubMedGoogle Scholar
  49. 22.
    Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A (2011) Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 261:575–582PubMedGoogle Scholar
  50. 23.
    Mirzakhani H, Welch CA, Eikermann M, Nostari A (2012) Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand 56:3–16PubMedCrossRefGoogle Scholar
  51. 24.
    Fredman B, Smith I, d’EtienneJ et al (1994) Use of musde relaxants for electroconvulsive therapy: how much is enough? Anesth Anaig 78:195–196Google Scholar
  52. 25.
    Batistaki C, Kesidis K, Apostolaki S, Kostopanagiotou G (2011) Rocuronium antagonized by sugammadex for seriesof electroconvulsive therapy (ECT) in a patient with pseudoCholinesterase deficiency. J ECT 27:e47e4–8Google Scholar
  53. 26.
    Bryson EO, Aloysi AS, Katz M et al (2011) Rocuronium as musde relaxant for electroconvulsive therapy in a patient with adult-onset muscular dystrophy. J ECT 27:e63–e64PubMedGoogle Scholar
  54. 27.
    Hoshi H, Kadoi Y, Kamiyama J et al (2011) Use of rocuronium-sugammadex, an alternative to succinylcholine, as a musde relaxant during electroconvulsive therapy. J Anesth 25:286–290PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • U. Grundmann
    • 1
  • S.O. Schneider
    • 1
  1. 1.Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieUniversitätsklinikum des Saarlandes, Homburg/SaarHomburg/Saar

Personalised recommendations